Some patients develop more acne early in isotretinoin treatment. People often call this an Accutane "purge," but that word does not diagnose the problem or establish that the worsening is safe to ignore. New acne, irritated skin and a severe inflammatory flare can look similar in a photograph while needing different responses.
The number of new lesions matters, but pain, speed of change and symptoms elsewhere in the body matter too. A difficult start should lead to a useful conversation with the prescriber rather than a rule that you must push through anything.
What an early flare means
Acne develops beneath the surface before a lesion becomes visible. Starting treatment does not instantly stop every lesion already forming. Some patients also experience an increase in inflammation early in a course. AAD patient guidance notes that worsening can last one or two months before clearance begins for some people. That is a possibility, not a required stage or a deadline for improvement. 5
The flare does not prove that toxins are leaving your skin. It also does not establish that the prescription needs a higher amount. The dermatologist should judge the course using the lesions, dose, symptoms and response so far.
Not everyone experiences this stage. If your skin improves without a flare, the absence of a "purge" does not suggest that the medicine failed to reach the follicles.
Acne or irritation?
Dryness can produce redness, stinging, peeling and small rough areas. Adding exfoliating acids or a topical retinoid can make those changes more obvious. Deep new nodules, pustules and painful swelling point toward a different type of problem from a surface that burns after cleansing.
| Change | A possible explanation | What helps the assessment |
|---|---|---|
| New inflamed lesions in familiar acne areas | Continuing acne activity or an early flare | Dates, photographs and the number of new painful lesions |
| Burning and peeling after applying products | Irritation on dry, sensitive skin | Exact product ingredients and application schedule |
| Rapid increase in deep pain or swelling | A more substantial inflammatory flare | Prompt clinical contact and a description of severity |
| Ulcerating lesions with fever or feeling unwell | A potentially serious inflammatory condition | Urgent medical assessment |
You do not need to identify the explanation correctly before contacting the clinic. Describing what changed gives the clinician a better starting point than deciding in advance that every lesion belongs to a purge.
How long should you watch it?
Use the prescriber's review plan and contact instructions. A gradual, tolerable change may fit the expected early course; rapidly worsening inflammation or new systemic symptoms should not wait for a calendar milestone.
Track the start date, current dose, any dose increase and changes to skin care. Comparable photographs can help, but constant close inspection can make minor variation feel like a daily crisis. Choose a record that supports the appointment without taking over your day.
If a symptom becomes difficult to tolerate, say so. Pain that interrupts sleep, lesions that bleed or an eruption spreading quickly deserves attention even if someone online reports a worse first month.
Can the dermatologist change the plan?
The clinician may review the starting dose, progression, additional treatment or the possibility of another diagnosis. NICE specifically advises considering a course of oral prednisolone if an acute significant flare occurs after starting isotretinoin. That is a supervised treatment decision, not a suggestion to use leftover steroid tablets. 3
A lower starting amount or slower increase may suit some patients. The decision balances inflammation, tolerability and the broader course. Do not halve, double or alternate doses without a clear instruction.
If another acne medicine remains in your routine, identify it precisely. Concurrent tetracycline antibiotics require particular caution because isotretinoin labeling advises avoiding that combination. The clinic should control any transition or temporary addition. 1, 2
What to do with skin care
Keep the routine simple while the clinician evaluates the flare. Use a gentle cleanser, moisturizer, lip protection and sunscreen. Avoid picking lesions or scrubbing rough areas away. Extra exfoliation cannot force deep inflammation to resolve more quickly.
Ask which previous acne products should remain. A familiar cream can become too irritating on isotretinoin, and a new spot treatment can add a second problem to the original flare.
Do not use home chemical peels or attempt to drain nodules. Both can add injury and make it harder to distinguish acne progression from a complication caused by treatment outside the prescription plan.
Warning signs that are not a routine purge
Fever, feeling acutely unwell, ulcerating painful lesions or severe rapid worsening calls for urgent assessment. A clinician may need to consider acne fulminans or another serious process rather than ordinary early treatment activity. 3
Symptoms outside the skin also need their own response. A severe headache with visual changes, major mood symptoms, a blistering rash or severe abdominal pain should not be filed under an acne flare. Follow the Medication Guide and obtain prompt care.
An online reassurance that "it gets worse before it gets better" cannot evaluate those symptoms. Your current condition takes priority over another patient's recovery story.
Does purging mean a better final result?
No dependable rule links the intensity of an early flare with the quality of the final result. More pain is not a treatment target. The prescriber can assess whether the course needs adjustment.
Can I prevent it by taking extra acne products?
Do not add products independently. They can irritate the skin or interact with the prescription. If your acne pattern suggests a higher flare risk, discuss the starting plan before the first dose.
What should I send the clinic?
Provide the treatment start date, current amount, recent changes, clear photographs and a description of pain or other symptoms. Include every acne medicine you still use so the clinician can review the full regimen.
Sources
- DailyMed. Isotretinoin capsules prescribing information, revised August 2026. View source
- FDA. Absorica and Absorica LD prescribing information, revised June 2026. View source
- NICE. Acne vulgaris: management, NG198. Recommendations, updated 2026. View source
- American Academy of Dermatology. Isotretinoin: FAQs. View source
- American Academy of Dermatology. Isotretinoin: safety, side effects and skin care. View source